
Antiphospholipid syndrome (APS) is a systemic autoimmune disorder characterized by a combination of arterial or venous thrombosis and recurrent fetal loss, accompanied by elevated titers of antiphospholipid antibodies (aPL). APS has been recognized as the leading cause of vascular thrombosis in children. The diagnostic and therapeutic approach to APS in childhood may be different from that for adults and because of the rarity of aPL-related thrombosis in children, the natural history and optimal management of APS can be defined only through large, multicenter, controlled studies.
Male, Venous Thrombosis, Adolescent, Antiphospholipid Syndrome, Diagnosis, Differential, Chickenpox, Antibodies, Antiphospholipid, Humans, Venae Cavae, Child, Tomography, X-Ray Computed
Male, Venous Thrombosis, Adolescent, Antiphospholipid Syndrome, Diagnosis, Differential, Chickenpox, Antibodies, Antiphospholipid, Humans, Venae Cavae, Child, Tomography, X-Ray Computed
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 45 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
